Cullinan Therapeutics, Inc. (CGEM) stock
CGEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$10.19−1.16 (-10.22%)
Close on Nov 12, 2026Market cap $655.77MP/E –Yield –
Cullinan Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Cullinan Therapeutics's operating margin for the twelve months ending Dec 31, 2021 was -358.7%. For fiscal 2021 it was -358.7%.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | -358.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2021 | Mar 31, 2021 | 7.2% | – |
See a number that looks wrong?